The cell and gene therapy (C>) fields of biomedical research have similar goals targeting DNA or RNA inside or outside the body by modifying genetic material to improve functioning or to fight disease. Cell therapy introduces new cells into a patient’s body to grow, replace, or repair damaged tissue to treat a disease.
Entegris is playing a supporting but crucial role in our customers’ efforts to develop and manufacture therapies for COVID-19. We have taken several critical steps to bolster supply chains, auditing, and validation programs, and are undergoing rapid scale-up to meet commercial demand for potential successful candidates in the pipeline. You can be certain that we are committed to remaining a strong partner and as such, have dedicated ourselves to maintaining critical operations by relying on our business continuity plans and leveraging trusted supply partners.